Latest News

Sign up for our RSS Feed.
29 Sep 2014 NeurOp Awarded NIH Grant for Alzheimer’s Disease Drug Research Read More
11 Aug 2014 Lee H. Latimer Joins NeurOp to Manage Its Chemistry Operations Read More
Press Releases
123...
29 Sep 2014

NeurOp Awarded NIH Grant for Alzheimer’s Disease Drug Research

ATLANTA, September 29, 2014 – NeurOp, Inc. announced today that the National Institutes of Health (NIH) has awarded it a grant to support research on new Alzheimer’s disease treatments. NeurOp is in ... Read More
11 Aug 2014

Lee H. Latimer Joins NeurOp to Manage Its Chemistry Operations

ATLANTA, August 11, 2014 – NeurOp, Inc. announces that Lee H. Latimer, Ph.D., has been appointed as its head of chemistry. He will oversee the company’s chemistry program to support its drug develop ... Read More
21 May 2014

NeurOp Selects NP10679 as Development Candidate for SAH

NeurOp, Inc. has selected NP10679 as a development candidate for the prevention of ischemic damage and its consequences in persons receiving surgical treatment for subarachnoid hemorrhage (SAH). NP1 ... Read More
11 Apr 2014

NeurOp Receives Third Year of NIH Funding for Ischemia Research

NeurOp, Inc. has received $700,000 in funding as part of a $3 million National Institutes of Health (NIH) award to support its cerebral ischemia development program. This third year of funding from th ... Read More
15 Apr 2013

NeurOp Receives Second Half of NIH Grant for Meeting Schizophrenia Research Milestones

NeurOp, Inc. has received $346,000 from the National Institutes of Health (NIH), the second half of a $700,000 grant made last year to support its schizophrenia treatment research. NeurOp is studying ... Read More
123...